Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
BsUFA IV: Approval Criteria Shift May Mean US FDA User Fee Changes
Dec 12 2025
•
By
Derrick Gingery
Will the BsUFA fee structure change to account for fewer applications requiring clinical data?
(Shutterstock)
More from User Fees
More from United States